HRT Financial’s NOVONIX NVX Stock Holding History

HRT Financial’s Portfolio NVX Stock Details NVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,445	Closed	-$37K	–	5008
2026 Q1	$37K	Buy	+5,445	New	+$52.9K	﹤0.01%	3496
2024 Q4	–	Sell	-3,424	Closed	-$63K	–	2991
2024 Q3	$63K	Sell	3,424 -3,857	-53%	-$64.1K	﹤0.01%	2085
2024 Q2	$130K	Buy	+7,281	New	+$163K	﹤0.01%	1728

Other funds holding NVX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FACM

Forest Avenue Capital Management Miami, Florida $2.38B AUM 88.67% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

HRT Financial's NVX Position: Q2 2026 in Review

HRT Financial sold out of NOVONIX (NVX) in Q2 2026, closing a stake of 5,445 shares — an estimated $37K sold.

HRT Financial first reported a position in NVX in Q2 2024 and held it in 3 quarters. The position peaked at $130K in Q2 2024. 25 funds tracked by Wall St. Rank hold NVX as of Q2 2026.

HRT Financial reported no remaining NOVONIX position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 5,445 NOVONIX shares in Q2 2026, an estimated $37K.
HRT Financial first reported a position in NOVONIX in Q2 2024 and held it in 3 quarters.
HRT Financial's NOVONIX position peaked at $130K in Q2 2024.
25 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.